ASCL5
geneOn this page
Also known as bHLHa47ASH-5AmeloD
Summary
ASCL5 (achaete-scute family bHLH transcription factor 5, HGNC:33169) is a protein-coding gene on chromosome 1q32.1, encoding Achaete-scute homolog 5 (Q7RTU5). Transcription factor.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in chromatin. Predicted to be part of RNA polymerase II transcription regulator complex.
Source: NCBI Gene 647219 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 2 total — 1 likely-pathogenic
- MANE Select transcript:
NM_001270601
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33169 |
| Approved symbol | ASCL5 |
| Name | achaete-scute family bHLH transcription factor 5 |
| Location | 1q32.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bHLHa47, ASH-5, AmeloD |
| Ensembl gene | ENSG00000232237 |
| Ensembl biotype | protein_coding |
| OMIM | 620809 |
| Entrez | 647219 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000449188
RefSeq mRNA: 1 — MANE Select: NM_001270601
NM_001270601
CCDS: CCDS59202
Canonical transcript exons
ENST00000449188 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001662950 | 201127084 | 201127184 |
| ENSE00001698446 | 201113943 | 201115877 |
Expression profiles
Bgee: expression breadth broad, 90 present calls, max score 61.40.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0334 / max 9.6912, expressed in 10 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 16604 | 0.0334 | 10 |
Top tissues by expression
216 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 61.40 | gold quality |
| prefrontal cortex | UBERON:0000451 | 56.82 | gold quality |
| nucleus accumbens | UBERON:0001882 | 54.15 | gold quality |
| pancreas | UBERON:0001264 | 53.53 | gold quality |
| gastrocnemius | UBERON:0001388 | 52.42 | gold quality |
| hypothalamus | UBERON:0001898 | 52.12 | gold quality |
| muscle of leg | UBERON:0001383 | 51.65 | gold quality |
| frontal cortex | UBERON:0001870 | 51.57 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 51.57 | gold quality |
| neocortex | UBERON:0001950 | 50.82 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 50.43 | gold quality |
| right frontal lobe | UBERON:0002810 | 49.99 | gold quality |
| stromal cell of endometrium | CL:0002255 | 49.85 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 49.44 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 49.08 | silver quality |
| ganglionic eminence | UBERON:0004023 | 48.83 | silver quality |
| cerebral cortex | UBERON:0000956 | 48.75 | gold quality |
| amygdala | UBERON:0001876 | 48.30 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 48.17 | silver quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 47.87 | gold quality |
| forebrain | UBERON:0001890 | 47.36 | gold quality |
| ventricular zone | UBERON:0003053 | 47.00 | gold quality |
| right coronary artery | UBERON:0001625 | 46.94 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 46.49 | gold quality |
| brain | UBERON:0000955 | 46.32 | gold quality |
| bone marrow cell | CL:0002092 | 46.31 | gold quality |
| buccal mucosa cell | CL:0002336 | 45.81 | gold quality |
| left ovary | UBERON:0002119 | 45.71 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 45.69 | silver quality |
| Ammon’s horn | UBERON:0001954 | 45.47 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.52 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
15 targeting ASCL5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-4649-3P | 99.56 | 66.90 | 1783 |
| HSA-MIR-7159-5P | 99.53 | 72.12 | 2472 |
| HSA-MIR-5693 | 99.24 | 66.67 | 1106 |
| HSA-MIR-622 | 98.99 | 66.48 | 1050 |
| HSA-MIR-7851-3P | 98.72 | 64.88 | 980 |
| HSA-MIR-6880-5P | 98.08 | 65.59 | 1282 |
| HSA-MIR-4456 | 97.50 | 64.88 | 1678 |
| HSA-MIR-15A-3P | 97.47 | 65.08 | 527 |
| HSA-MIR-4529-5P | 96.74 | 65.77 | 569 |
| HSA-MIR-151A-5P | 95.79 | 68.73 | 162 |
| HSA-MIR-151B | 95.79 | 68.73 | 162 |
| HSA-MIR-4749-5P | 92.16 | 62.26 | 179 |
| HSA-MIR-6767-5P | 90.00 | 62.41 | 97 |
| HSA-MIR-6089 | 89.72 | 61.35 | 324 |
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ascl5 | ENSMUSG00000097918 |
| rattus_norvegicus | Ascl5 | ENSRNOG00000033391 |
| drosophila_melanogaster | ac | FBGN0000022 |
| drosophila_melanogaster | ase | FBGN0000137 |
| drosophila_melanogaster | l(1)sc | FBGN0002561 |
| drosophila_melanogaster | sc | FBGN0004170 |
| caenorhabditis_elegans | WBGENE00001958 |
Paralogs (4): ASCL1 (ENSG00000139352), ASCL3 (ENSG00000176009), ASCL2 (ENSG00000183734), ASCL4 (ENSG00000187855)
Protein
Protein identifiers
Achaete-scute homolog 5 — Q7RTU5 (reviewed: Q7RTU5)
Alternative names: Class A basic helix-loop-helix protein 47
All UniProt accessions (1): M0R2M9
UniProt curated annotations — full annotation on UniProt →
Function. Transcription factor. Probably binds E-box motifs 5’-CANNTG-3’ in complex with transcription factor TCF3/E12. Negatively modulates transcription of target genes such as CDH1/E-cadherin, perhaps by recruiting the PRC2 repressive complex to regulatory elements. Regulates ameloblast development and tooth germ growth, perhaps acting by positively modulating migration of inner enamel epithelium (IEE) cells. Plays a role in enamel formation.
Subunit / interactions. Interacts with transcription factor TCF3/E12.
Subcellular location. Nucleus.
RefSeq proteins (1): NP_001257530* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011598 | bHLH_dom | Domain |
| IPR036638 | HLH_DNA-bd_sf | Homologous_superfamily |
| IPR050283 | E-box_TF_Regulators | Family |
Pfam: PF00010
UniProt features (5 total): region of interest 3, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7RTU5-F1 | 64.17 | 0.19 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 17 (showing top):
GOBP_EPITHELIUM_DEVELOPMENT, GOCC_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATOR_COMPLEX, GOCC_TRANSCRIPTION_REGULATOR_COMPLEX, GOMF_PROTEIN_DIMERIZATION_ACTIVITY, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ID1_TARGET_GENES, GOCC_NUCLEAR_PROTEIN_CONTAINING_COMPLEX, CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_RNA_BIOSYNTHETIC_PROCESS
GO Biological Process (7): regulation of transcription by RNA polymerase II (GO:0006357), animal organ development (GO:0048513), epithelium development (GO:0060429), negative regulation of transcription by RNA polymerase II (GO:0000122), ameloblast differentiation (GO:0036305), positive regulation of transcription by RNA polymerase II (GO:0045944), amelogenesis (GO:0097186)
GO Molecular Function (8): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), protein dimerization activity (GO:0046983), RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228), DNA binding (GO:0003677), DNA-binding transcription factor binding (GO:0140297)
GO Cellular Component (4): chromatin (GO:0000785), RNA polymerase II transcription regulator complex (GO:0090575), nucleus (GO:0005634), transcription regulator complex (GO:0005667)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 4 |
| transcription by RNA polymerase II | 3 |
| regulation of transcription by RNA polymerase II | 3 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 2 |
| regulation of DNA-templated transcription | 1 |
| anatomical structure development | 1 |
| tissue development | 1 |
| negative regulation of DNA-templated transcription | 1 |
| columnar/cuboidal epithelial cell differentiation | 1 |
| positive regulation of DNA-templated transcription | 1 |
| odontogenesis of dentin-containing tooth | 1 |
| anatomical structure formation involved in morphogenesis | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription repressor activity | 1 |
| protein binding | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription activator activity | 1 |
| positive regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| transcription factor binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| transcription regulator complex | 1 |
| nuclear protein-containing complex | 1 |
| intracellular membrane-bounded organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
320 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ASCL5 | ACSL5 | Q9ULC5 | 541 |
| ASCL5 | BHLHE23 | Q8NDY6 | 540 |
| ASCL5 | BHLHA9 | Q7RTU4 | 532 |
| ASCL5 | TMEM170B | Q5T4T1 | 483 |
| ASCL5 | TCF24 | Q7RTU0 | 389 |
| ASCL5 | H1-0 | P07305 | 371 |
| ASCL5 | ZNF316 | A6NFI3 | 370 |
| ASCL5 | MFSD6L | Q8IWD5 | 323 |
| ASCL5 | C2orf69 | Q8N8R5 | 316 |
| ASCL5 | TCF23 | Q7RTU1 | 312 |
| ASCL5 | H2AL3 | A0A3B3IU63 | 311 |
| ASCL5 | FTCDNL1 | E5RQL4 | 311 |
| ASCL5 | GPR25 | O00155 | 297 |
| ASCL5 | TYW5 | A2RUC4 | 296 |
| ASCL5 | ZNF141 | Q15928 | 293 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ASCL5 | H1-5 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ASCL5 | H1-2 | psi-mi:“MI:0915”(physical association) | 0.400 |
ESM2 similar proteins: A0A0U1RRK4, A0A1W2PPE3, A0A1W2PR82, A0A2R8Y2Y2, A0A494C0N9, A0A494C0Y3, A0JNN8, A6NF83, A6NHQ4, A6QPM6, A8E4L3, A8MTW9, B2KGE5, C9JVW0, I3L1E1, O43541, O75474, O75638, P0C7X2, P70339, P89439, Q02080, Q05215, Q12950, Q3SYB3, Q5T230, Q5VV16, Q6NZ36, Q6NZY7, Q6P1X6, Q6VB84, Q6VUC0, Q6VUP9, Q6ZSJ8, Q7RTU5, Q7TNS8, Q80WY3, Q86SI9, Q86UU5, Q8K025
Diamond homologs: A8E5T6, M0QWB7, O35437, O35885, O43680, O60682, O73615, O73823, O88940, O93507, O96004, O96642, P09774, P09775, P10083, P10084, P10627, P13903, P17542, P19359, P19360, P22091, P24899, P26687, P27792, P34555, P46581, P48985, P50553, P57100, P57101, P57102, P59101, P61295, P61296, P79782, P97831, P97832, Q02067, Q02575
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3358881 | NM_001270601.2(ASCL5):c.274G>A (p.Glu92Lys) | Likely pathogenic |
SpliceAI
228 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:201114636:T:TA | donor_gain | 0.9400 |
| 1:201114816:TCCGG:T | donor_gain | 0.9200 |
| 1:201114817:CCGGC:C | donor_gain | 0.9200 |
| 1:201114579:T:TA | donor_gain | 0.9100 |
| 1:201114641:CAG:C | donor_gain | 0.9100 |
| 1:201114692:C:CA | donor_gain | 0.9000 |
| 1:201114650:T:TA | donor_gain | 0.8900 |
| 1:201114958:G:C | donor_gain | 0.8500 |
| 1:201114643:G:C | donor_gain | 0.8300 |
| 1:201114973:A:AC | donor_gain | 0.8100 |
| 1:201114974:C:CC | donor_gain | 0.8100 |
| 1:201114523:TC:T | donor_gain | 0.8000 |
| 1:201114580:C:A | donor_gain | 0.7700 |
| 1:201114721:T:TA | donor_gain | 0.7500 |
| 1:201114975:T:C | donor_gain | 0.7400 |
| 1:201114382:CGCCT:C | acceptor_loss | 0.7200 |
| 1:201114383:GCCTG:G | acceptor_loss | 0.7200 |
| 1:201114385:C:A | acceptor_loss | 0.7200 |
| 1:201114386:T:A | acceptor_loss | 0.7200 |
| 1:201114570:C:A | donor_gain | 0.7100 |
| 1:201114563:CCCG:C | donor_gain | 0.7000 |
| 1:201114553:G:A | donor_gain | 0.6900 |
| 1:201114589:G:C | donor_gain | 0.6900 |
| 1:201114765:T:TA | donor_gain | 0.6900 |
| 1:201114642:A:C | donor_gain | 0.6800 |
| 1:201114675:AACAG:A | donor_gain | 0.6800 |
| 1:201114775:C:CA | donor_gain | 0.6800 |
| 1:201114521:CT:C | donor_gain | 0.6700 |
| 1:201114522:TT:T | donor_gain | 0.6700 |
| 1:201114970:G:C | donor_gain | 0.6600 |
AlphaMissense
1296 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000229543 (1:201122892 C>A), RS1000417627 (1:201117487 C>T), RS1000533832 (1:201117234 G>A), RS1000560651 (1:201121600 C>A), RS1000747570 (1:201115661 A>G), RS1000904375 (1:201126605 C>A,T), RS1000952953 (1:201115432 C>T), RS1000990149 (1:201121437 T>C), RS1001379310 (1:201126283 G>T), RS1001523714 (1:201126920 G>A), RS1001556792 (1:201122266 C>T), RS1001621940 (1:201120981 G>A), RS1001650170 (1:201122046 C>T), RS1001777462 (1:201122625 G>A,T), RS1002153985 (1:201116181 T>TA)
Disease associations
OMIM: gene MIM:620809 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005389_1 | Tooth agenesis | 2.000000e-16 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): tooth agenesis